Health care stocks fell Tuesday afternoon with the NYSE Health Care Index shedding 0.5% and the Health Care Select Sector SPDR Fund (XLV) down 0.4%.
The iShares Biotechnology ETF (IBB) was little changed, erasing earlier gains.
In corporate news, Surgery Partners (SGRY) shares jumped 18%. Bain Capital Partners delivered a non-binding proposal late Monday to Surgery Partners' board proposing to buy the remaining shares for $25.75 apiece in cash.
Silexion Therapeutics (SLXN) shares surged 79% after the company reported "promising" preclinical data from its tumor drug candidate, SIL-204, in mice.
Trinity Biotech (TRIB) shares jumped 53% after the company said the latest pre-pivotal trial for its continuous glucose monitoring technology yielded "breakthrough" results.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。